preloder

INVERTIR EN LONGEVIDAD

Gama completa de condiciones de vida para la longevidad
Sabemos cómo mejorar tu vida ahora
Formar parte de un ecosistema descentralizado
LONGEVIDAD GLOBAL

Private ICO round successfully completed.

1 LONGEVITY = 0,00001 ETH
During the private ICO stage, institutional investors acquired 2 billion LGV, while receiving a 10% bonus.
SOBRE PROYECTO
La longevidad global es un ecosistema descentralizado y escalable que crea un espectro completo de condiciones de vida para una longevidad de calidad. Utiliza todos los logros más recientes de world science y trabaja en la plataforma de TI para la gestión personalizada de la vida útil basada en blockchain, redes neuronales y aprendizaje automático.
El token de software Longevity es generado por Global Longevity y proporciona a sus propietarios acceso a los servicios actuales y futuros de la compañía. Global Longevity incorpora las mejores tecnologías y años de experiencia en el mercado de la longevidad.

LONGEVITY ES LA UTILIDAD DE SIMBÓLICO

Al ser una herramienta no financiera, brinda a los propietarios acceso a los servicios y productos de Global Longevity que se pueden comprar en el Global Longevity Market.

NUESTRA MISIÓN

La misión de Global Longevity es brindar a las personas una oportunidad real de extender la vida a través del uso de la ciencia avanzada de la tecnología de longevidad.

Formar parte de un ecosistema descentralizado

LONGEVIDAD GLOBAL

0
5

CONTINENTS

0
18

COUNTRIES

0
256

INVESTORS

0
36

PARTNERS

0
122

EMPLOYEES

Ukraine
Singapore
Germany
Georgia
Israel
China
Mexico
Sri Lanka
Brazil
Turkey
Ecuador
Peru
South Africa
Argentina
Vietnam
India
Costa Rica
Australia

NO SEAS UN INVITADO EN LA VIDA

¡CONVIÉRTETE EN SU ANFITRIÓN!

Decidí vivir para siempre. Y tan lejos todo va bien.

Autor desconocido

QUE SE PUEDE COMPRAR POR LONGEVITY

APARTAMENTOS Y TERRENO CERCA DEL MAR (COMPRA Y ALQUILER)

El deseo de comprar una propiedad en atractivos centros turísticos y áreas recreativas también abre amplias perspectivas y oportunidades. Especialmente popular entre los ciudadanos extranjeros es la región de Georgia, Ajaria y, en particular, la ciudad de Batumi, una ciudad portuaria, donde buscan un sabor único.

DIAGNOSTICO Y TRATAMIENTO

Un diagnóstico completo del cuerpo significa un examen completo, que se lleva a cabo con la ayuda de dispositivos especiales y mediante la entrega de varias pruebas. Los datos obtenidos nos permiten hacer un panorama completo del estado de la salud humana, sus órganos internos y las nuevas formaciones, tanto benignas como malignas.

ASISTENCIA LEGAL

La alta eficiencia de los servicios prestados se debe a los principios que nos guían. Este es un nivel profesional de capacitación de abogados, enfoque personal para cada cliente, responsabilidad por la calidad de los servicios, enfoque en los deseos e intereses de sus directores.

PRODUCTOS FARMACOLOGICOS

Esta industria está relacionada con la investigación, el desarrollo, la producción en masa, la investigación de mercado y la distribución de medicamentos, principalmente destinados a la prevención, el alivio y el tratamiento de enfermedades. Actualmente, la industria farmacéutica es una de las industrias más exitosas.

PRODUCTOS DE ALIMENTOS ORGÁNICOS PARA LA LONGEVIDAD GLOBAL

En todo el mundo, la producción de alimentos orgánicos está en auge. Este alimento contiene en promedio de 10 a 50% más de vitaminas, minerales y otros nutrientes en comparación con los productos producidos por las tecnologías modernas. Los alimentos orgánicos mejoran la salud, aumentan la inmunidad y, sobre todo, son útiles para niños, mujeres embarazadas y madres lactantes.

Servicios turísticos

Si te gusta respirar viento fresco, despiértate con el canto de los pájaros y el murmullo del arroyo, querrás sumergirte en el maravilloso mundo de la aventura: ¡has venido al lugar correcto!

MINERÍA

La experiencia de Global Longevity en este campo nos ha ayudado a establecer asociaciones con los principales fabricantes de equipos y empresas de tecnología, lo que nos permitirá ayudar a nuestros clientes de manera exitosa y rentable en el futuro.

PROMOCION ICO & STO

Uno puede lograr todos los objetivos con éxito solo cuando las habilidades profesionales se combinan adecuadamente. Cada miembro de nuestro equipo es un profesional capacitado, que se concentra en el alcance.

SIMBÓLICO
Absolutamente, todo el volumen de tokens emitidos está completamente provisto de bienes y servicios que se proporcionan en nuestro Mercado de Longevidad Global, incluso si el costo de 1 Longevity (0,00001 ETH) es igual a 0,001 ETH. Así, hoy en día, el potencial de crecimiento inicial del token es 9900%.
Name: LONGEVITY
Ticker: LGV
Type: ERC-20
Platform: Ethereum
Token Type: Utility
Token Price: 0,00001 ETH
Soft Cap: none
Hard Cap: 1.000.000 LGV
Return on Invest: long-term token value increase
Purchase methods accepted: All Leading Crypto and Fiat
Total token supply: 100.000.000.000 LGV
Private-sale & Public Sale: 89.000.000.000 LGV
Team: 5.000.000.000 LGV
Advisors: 3.000.000.000 LGV
Marketing Activities and Bounty: 3.000.000.000 LGV

PORCENTAJE DE DISTRIBUCIÓN DE TOKENS

ASIGNACIÓN Y USO DE FONDOS

NOTES

  • Team’s token will be locked for 30 months after the Private-sale & Public Sale
  • Tokens for Marketing team and Bounty will be locked for 6 months after the Private-sale & Public Sale
Investor Exclusions: Afghanistan, Angola, Aruba, Australia, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Central Africa republic, Chad, China, Comoros, Congo, Congo Democratic republic, Cuba, Cote d´lvoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iran, Iraq, Japan, Jordan, Kenya, Kyrgytz Republic, Laos, People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Myanmar, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, North Korea, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Republic of Korea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, United States, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia.
MAPA VIAL
Jan 2014
Official opening Global Longevity Institute
Mar 2014
Approval of the concept of creating an ecosystem within the program of Global Longevity
Nov 2014
Selection and approval of the region for the pilot project of Global Longevity
Jan 2015
Initiation of a material base for a pilot project of Global Longevity
May 2017
Completion of work on the creation of a material basis for the pilot project of Global Longevity
Jul 2017
Deciding on the implementation of blockchain and cryptocurrency in the project of Global Longevity
Jan 2018
Start preparation for ICO Global Longevity
Dec 2018
Cryptocurrency issue Longevity
May 2019
Start Pre ICO
Jun 2019
Start ICO
Jul 2020
Full launch of the Global Longevity project
EQUIPO Y ASESORES

Elina Mahzhalii

CEO (Chief Executive Officer),
CEO Global Longevity Institute

Wolfgang Stremmel

Professor of Internal Medicine IV

Soeharto Lee

Professor of Medicine, Longevity Technology Expert

Akaki Lomadze

Doctor of Medicine, Male Health Expert

HAZ UN PASO HACIA

LONGEVIDAD!

FOGONADURA
NOTICIAS Y PUBLICACIONES
(PUBLICACIONES PLANIFICADAS PARA PUBLICACIÓN)
PÓNGASE EN CONTACTO CON NOSOTROS

 

Global Longevity Disclaimer

Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

Potential investors should note that participation in the Global Longevity Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

Potential investors should note that participation in the Global Longevity project Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Global Longevity project. Investors should make their decision to buy or to subscribe to Global Longevity project.

Investors are furthermore advised to consult their bank or financial adviser before making any investment decision. This publication may contain specific forward-looking statements, e.g. statements including terms like “believe”, assume”, “expect”, “forecast”, “project”, “may”, “could”, “might”, “will” or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements.

Against the background of these uncertainties, readers should not rely on forward-looking statements. Global Longevity project assumes no responsibility to update forward-looking statements or to adapt them to future events or developments. The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, in any jurisdiction in which such offer or solicitation would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction.

The Global Longevity project are not for sale and distribution, directly or indirectly, in or into the United States (including its territories and dependencies, any state of the United States and the District of Columbia), Canada, Japan, Australia, North Korea, Iran, Myanmar, Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde, Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction into which the same would be unlawful.

This announcement does not constitute or form a part of any offer or solicitation to purchase, subscribe for or otherwise acquire securities in the United States, Canada, Japan, Australia, North Korea, Iran, Myanmar,Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde,Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction in which such an offer or solicitation is unlawful.

The Global Longevity project will not be registered under the US Securities Act of 1933, as amended or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States.

The Global Longevity project have not been approved or disapproved by the US Securities and Exchange Commission, any state’s securities commission in the United States or any US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of the Global Longevity project or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States. The information contained herein does not constitute an offer of securities to the public in the United Kingdom. No prospectus offering securities to the public will be published in the United Kingdom.

This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). The Global Longevity project are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such the Global Longevity project will be engaged in only with, relevant persons.

Any person who is not a relevant person should not act or rely on this document or any of its contents. Any offer of securities to the public that may be deemed to be made pursuant to this communication in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”) is only addressed to qualified investors in that Member State within the meaning of the Prospectus Directive.